Mast Therapeutics, Inc. (MSTX)

[Rhodey Red]

Yesterday's corporate presentation was excellent. We received a very clear and concise outlook for the next 16 months. The schedule of company milestones through Q4'15 is chock full of important events culminating of course with the P3 EPIC and P2 ALI completion dates on 12/15!! I won't go through every piece of the corporate presentation because it's right there on the website slide by slide for everyone to read!!
Again I was pleased that the company continues to deliver promised events on time. That is very important for me personally as an investor. The CRaDA with the military for major trauma was great to see. The progress in developing our heart failure indication is very exciting. EPIC enrollment being on schedule is very encouraging. And next up for us is AIR001 data at some point within the next 6 weeks (Q3)
IMO our pipeline is looking stronger every update and the next 12-17 months should be very positive for MAST and its investors.